The rounds this investor is named on, who it invests beside, and where it shows up.
Named on one round in the feed.
metavallon.vcSince 2026-09-21
| Company | Round | Amount | Announced | Role |
|---|---|---|---|---|
Anacalypsis Therapeutics A startup focused on treatments for LRRK2-associated Parkinson's disease | Pre-seed Published on thinner evidence, 3 sources | n/a | 2026-09-21 | [ LEAD ] |
No one else named on these rounds.